Trade Ideas

Actionable trade ideas with defined risk and time horizons.

Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.

Articles

337 total articles

UnitedHealth: Buy the Market Leader After a Policy-Driven Washout

UnitedHealth: Buy the Market Leader After a Policy-Driven Washout

UnitedHealth (UNH) is a structurally advantaged insurer and healthcare services platform that just got cheaper after a policy surprise and disappointing top-line guidance. Fundamentals still show strong free cash flow, a reasonable valuation and operating leverage through Optum. This trade buys the dip with a defined stop and a 180 trading-day targ…

Meta’s Next Leg Up: Why $900 Is a Realistic 2026 Target

Meta’s Next Leg Up: Why $900 Is a Realistic 2026 Target

Meta surged after Q4 strength and looks set to extend gains as AI tailwinds roll through its ad and infrastructure businesses. Valuation is reasonable given free cash flow strength and low leverage. This trade plan targets $900 over the next 180 trading days with a strict stop at $640 to respect the technical picture and protect against macro-drive…

Why Sportradar (SRAD) Is One of My Highest-Conviction Longs for 2026

Why Sportradar (SRAD) Is One of My Highest-Conviction Longs for 2026

Sportradar is a market leader in sports data and betting technology with accelerating margins, a string of strategic deals (IMG ARENA, Bundesliga expansion), active buybacks and a current technical oversold setup. At a market cap of ~$5.8B and rich but justifiable growth expectations, I view SRAD as a long-term trade for investors willing to tolera…

Buy HTGC for Yield and Upside: A Retirement-Friendly BDC Trade

Buy HTGC for Yield and Upside: A Retirement-Friendly BDC Trade

Hercules Capital (HTGC) offers an 8%-9% yield, a modest P/E near 11 and a P/B around 1.5. For income-seeking investors who can tolerate credit and rate volatility, HTGC presents a balanced long trade: collect a high dividend while holding for potential capital appreciation as credit performance and rate expectations normalize.

Chemours 2026: Re-rate Catalyzed by HFE Shortage and Opteon Momentum

Chemours 2026: Re-rate Catalyzed by HFE Shortage and Opteon Momentum

Chemours (CC) looks set to re-rate in 2026 as tight supply for high-purity hydrofluoroethers, steady demand for Opteon refrigerants, and improving technical momentum combine with a cheap starting valuation versus enterprise value. We present a long trade with entry at $15.10, stop at $13.00 and a $22.00 target over a 46-180 trading day time frame.

Buy EXEL Ahead of a Potential FDA Win — Risk-Weighted Mid-Term Trade

Buy EXEL Ahead of a Potential FDA Win — Risk-Weighted Mid-Term Trade

Exelixis (EXEL) is a profitable oncology company trading near $42.67 with solid free cash flow, low leverage and a pipeline catalyst in zanzalintinib. A favorable FDA outcome could push the stock toward the mid-$40s to $50s; the trade below balances upside with a clear stop and a mid-term time horizon tied to a likely near-term regulatory event.

QuantumScape: From Options Trade to Manufacturing Blueprint

QuantumScape: From Options Trade to Manufacturing Blueprint

QuantumScape has moved beyond lab headlines into real vehicle testing and pilot production. With a market cap near $6.0B and a string of OEM and materials partnerships, the risk/reward favors a disciplined long position that targets bet-the-technology upside while protecting capital against execution failure.

Okta: How AI Agents Can Turn Identity Into a New Revenue Engine

Okta: How AI Agents Can Turn Identity Into a New Revenue Engine

Okta sits squarely at the intersection of identity and emergent enterprise AI agents. Identity is a prerequisite for secure agent actions; that makes Okta a natural beneficiary if customers adopt agentic workflows widely. Valuation already reflects a pullback from the 52-week high and a $1 billion buyback set to cushion share count. This trade targ…

Alico: Hidden Land Value and a Path to Re-Rating

Alico: Hidden Land Value and a Path to Re-Rating

Alico (ALCO) is a small-cap agricultural holding that is quietly pivoting from pure citrus production toward land management and real estate monetization. With a newly expanded $95M credit facility, a dedicated EVP of Real Estate, and management guidance for ~$20M in land sales this fiscal year, the stock looks positioned for a re-rating if managem…

Buy Mercado Libre: Own Latin America's E-commerce + Fintech Compounder

Buy Mercado Libre: Own Latin America's E-commerce + Fintech Compounder

Mercado Libre (MELI) is the dominant e-commerce and fintech platform across Latin America. With rising transaction take-rates, accelerating fintech adoption, and $8.61B in free cash flow, MELI offers a compounding growth story. This trade idea lays out an actionable long trade with entry at $2270.23, a $2850 target and a $2000 stop loss over a long…

Dycom: Tactical Long Into Data-Center Momentum With Defined Risk

Dycom: Tactical Long Into Data-Center Momentum With Defined Risk

Dycom's pivot into data-center electrical work and a record backlog make a compelling tactical long. The balance sheet, free cash flow and recent operational beats underwrite a trade that targets continued contract wins and integration upside from Power Solutions. This is a risk-managed idea — entry at $372, stop $350, target $420 — with clear trig…